Literature DB >> 8386729

Inhibition of tyrosine phosphorylation prevents delayed neuronal death following cerebral ischemia.

M S Kindy1.   

Abstract

Protein tyrosine phosphorylation plays an important role in the regulation of neuronal function. We examined the effects of inhibition of tyrosine phosphorylation on ischemic neuronal damage in the CA1 region of the hippocampus. In the gerbil hippocampus, genistein and lavendustin A, tyrosine kinase inhibitors, were administered 30 min before initiation of 5-min ischemia and reperfusion. Both genistein and lavendustin A blocked tyrosine phosphorylation and prevented delayed neuronal death (DND). However, genistein, an inactive analogue of genistein, did not block DND. Genistein was dose-dependent in the inhibition of DND after ischemia and reperfusion. Administration of genistein 5 to 10 min after ischemia and reperfusion was ineffective in blocking DND in the CA1 region of the hippocampus. The tyrosine kinase inhibitors selectively blocked the phosphorylation of microtubule-associated protein (MAP)-2 kinase following ischemia and reperfusion injury. These results suggest that tyrosine phosphorylation in the ischemic brain is important for neuronal injury and that MAP-2 kinase may play a role in the onset of delayed neuronal death.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386729     DOI: 10.1038/jcbfm.1993.50

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  17 in total

Review 1.  Receptor protein tyrosine phosphatase from stem cells to mature glial cells of the central nervous system.

Authors:  Smaragda Lamprianou; Sheila Harroch
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Genistein exerts neuroprotective effect on focal cerebral ischemia injury in rats.

Authors:  Adem Bozkurt Aras; Mustafa Guven; Tarik Akman; Hasan Alacam; Yildiray Kalkan; Coskun Silan; Murat Cosar
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

3.  Modulation of GABAA receptor function by tyrosine phosphorylation of beta subunits.

Authors:  Q Wan; H Y Man; J Braunton; W Wang; M W Salter; L Becker; Y T Wang
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

4.  Protein tyrosine kinase is required for the induction of long-term potentiation in the rat hippocampus.

Authors:  C C Huang; K S Hsu
Journal:  J Physiol       Date:  1999-11-01       Impact factor: 5.182

Review 5.  Phospholipases A2 in ischemic and toxic brain injury.

Authors:  A Sapirstein; J V Bonventre
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

6.  MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia.

Authors:  A Alessandrini; S Namura; M A Moskowitz; J V Bonventre
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 7.  Polyphenols in cerebral ischemia: novel targets for neuroprotection.

Authors:  Agnes Simonyi; Qun Wang; Rebecca L Miller; Mozow Yusof; Phullara B Shelat; Albert Y Sun; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

8.  Dietary soy may not confound acute experimental stroke infarct volume outcomes in ovariectomized female rats.

Authors:  Kamm D Prongay; Anne D Lewis; Patricia D Hurn; Stephanie J Murphy
Journal:  Lab Anim       Date:  2010-02-10       Impact factor: 2.471

9.  Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism.

Authors:  E Rundén; P O Seglen; F M Haug; O P Ottersen; T Wieloch; M Shamloo; J H Laake
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

10.  Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia.

Authors:  S Namura; K Iihara; S Takami; I Nagata; H Kikuchi; K Matsushita; M A Moskowitz; J V Bonventre; A Alessandrini
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.